What Is the End-of-Life Journey for Glioblastoma (GBM)?

The short answer: Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor, with median survival of 14–16 months after diagnosis. The end-of-life journey with GBM involves progressive cognitive and neurological decline, personality changes, and often a relatively sudden final decline. Early doula engagement is crucial.

Understanding Glioblastoma's Trajectory

GBM progresses through typical phases:

• Active treatment phase: Surgery, radiation, temozolomide chemotherapy. Most patients have some functional stability during treatment.
• Progression: When GBM progresses on first-line therapy, second-line options (bevacizumab, re-irradiation, clinical trials) may provide temporary control.
• End-stage decline: Progressive neurological decline—weakness, speech changes, seizures, fatigue. Corticosteroids (dexamethasone) help manage brain swelling but have significant side effects.
• Final weeks: Typically rapid—increasing somnolence, cessation of eating and drinking, and peaceful death within days to weeks of the final decline.

Personality and Cognitive Changes

Frontal and temporal lobe GBMs can cause significant personality changes—disinhibition, emotional lability, impulsivity, or apathy. Families grieve the personality changes before the physical death. This anticipatory grief for "who they used to be" is profound and often invisible to outsiders.

Steroid Side Effects and End-of-Life Decisions

Dexamethasone controls brain swelling but causes significant side effects—weight gain, mood swings, hyperglycemia, muscle weakness, and increased infection risk. At end of life, the decision to taper or stop steroids is significant—stopping steroids accelerates neurological decline but reduces side effects. A death doula helps families navigate this decision emotionally.

Why Early Doula Engagement Matters

GBM's relatively short and predictable decline makes early engagement essential. Legacy recording, advance care planning, and important family conversations should happen early—while cognitive function is preserved.

Frequently Asked Questions

When does a GBM patient qualify for hospice?

GBM patients may qualify for hospice when their Karnofsky Performance Status declines significantly (typically below 50%) and they are no longer pursuing active treatment. Average time from hospice enrollment to death in GBM is 4–8 weeks, but hospice can be enrolled earlier.

What causes death in glioblastoma?

GBM causes death through brain herniation (progressive tumor growth and edema compressing critical brain structures), aspiration pneumonia (due to swallowing difficulties from neurological decline), or progressive loss of brain function supporting vital systems.

Should I stop steroids at end of life for GBM?

This is a complex medical and values-based decision made with the hospice physician. Stopping steroids allows the disease to progress faster (may mean fewer days to death) but eliminates significant side effects and may improve comfort. Many families choose to taper steroids at end of life when comfort is the priority.

Can a GBM patient still have meaningful conversations at end of life?

Often yes, particularly early in the final decline. Cognitive function is preserved more in some GBM patients than others. When speech and language areas are not affected, patients can often communicate until very close to death.

Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.